Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/24/23 06:03 | 5/22/23 | PHGE | Health | BioPrd | Biological Products, (No Diag | Oron Assaf | L3 | O | Chief Bu | P | 1 | 0.2731 | 0 | 3 | 41 | 11 | D | ||||||||||||||
5/22/23 16:01 | 5/18/23 | PHGE | Health | BioPrd | Biological Products, (No Diag | Oron Assaf | L3 | O | Chief Bu | P.m | 2 | 0.2796 | 0 | 8 | New | 8 | D | ||||||||||||||
3/17/23 16:29 | 2/27/23 | PHGE | Health | BioPrd | Biological Products, (No Diag | Orbimed Israel Biofund Gp Limited Partnership | L3 | T | P.d | 85 | 0.2450 | 0 | 348 | 12 | 3,161 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |